Visgeneer Inc. is a Taiwan-based company principally engaged in the manufacture and sales of medical test strips and equipment. The Company's main products include blood glucose testers, blood glucose test strips and skin care products. The Company distributes its products in domestic market and to overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
22/09/26	NT$9.260	-0.54%	28,006
21/09/26	NT$9.310	-0.11%	55,506
18/09/26	NT$9.320	+0.32%	101,613
17/09/26	NT$9.290	+0.54%	16,806
16/09/26	NT$9.240	+0.54%	86,114

End-of-day quote Taipei Exchange

More quotes

End-of-day quote Taipei Exchange 22/09/2026			5-day change	1st Jan Change
9.260 ^TWD	-0.54%		+0.76%	-4.54%

08-12	Visgeneer Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-27	Visgeneer Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	279M 8.82M 7.71M 7.25M 6.61M 12.41M 843M 12.41M 86.96M 33.56M 431M 33.13M 32.4M 1.39B	P/E 2024	-16.6x	P/E 2025	55.8x
Enterprise Value	315M 9.94M 8.69M 8.16M 7.45M 13.98M 950M 13.98M 97.98M 37.81M 485M 37.33M 36.51M 1.56B	EV / Sales 2024	2.93x	EV / Sales 2025	1.83x
Free-Float	72.44%	Yield 2024 *	-	Yield 2025	-

08-12	Visgeneer Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-27	Visgeneer Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
14/08/25	Visgeneer Inc. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
06/08/25	U.S. Department of Health and Human Services Food and Drug Administration Issues the Warning Letter	CI
22/04/25	Visgeneer Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
13/08/24	Visgeneer Inc. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24/04/24	Visgeneer Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
14/08/23	Visgeneer Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
21/04/23	Visgeneer Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
12/08/22	Visgeneer Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	CI
27/04/22	Visgeneer Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
12/08/21	Visgeneer Inc. Reports Earnings Results for the Half Year Ended June 30, 2021	CI
13/04/21	Visgeneer Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	CI

1 day	-0.54%
1 week	+0.76%
Current month	+8.05%
1 month	+8.05%
3 months	+4.16%
6 months	-1.49%
Current year	-4.54%

Visgeneer Inc. Stock

Stocks

4197

TW0004197009

Medical Equipment, Supplies & Distribution

Valuation: Visgeneer Inc.

Chart: Visgeneer Inc.

Latest news: Visgeneer Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Visgeneer Inc.

Medical Equipment

Financials

Company Profile

Quotes

1 week	8.87	9.33
1 month	8.16	14.7
Current year	7.77	22.5
1 year	7.77	22.5
3 years	7.77	22.5
5 years	7.77	22.5
10 years	7.77	45.1

Manager	Title	Age	Since
Keng Shuo Tai CEO	Chief Executive Officer	-	15/11/2005
Shu Chen Li DFI	Director of Finance/CFO	-	06/08/2020

Director	Title	Age	Since
Keng Shuo Tai CHM	Chairman	-	07/11/2005
Huo Fu Tai BRD	Director/Board Member	-	07/11/2005
Fen Ho BRD	Director/Board Member	-	07/11/2005

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VISGENEER INC.	-0.54%	+0.76%	-21.19%	-21.19%	8.82M
PENUMBRA, INC.	+0.19%	+0.30%	+25.91%	+29.03%	12.58B
GETINGE AB	+1.95%	+3.11%	+15.15%	+22.50%	6.78B
MINIMED GROUP, INC.	+0.38%	-3.68%	-	-	5.96B
ASAHI INTECC CO., LTD.	-0.21%	+0.68%	+26.01%	+22.20%	5.52B
APT MEDICAL INC.	-0.03%	-0.74%	-18.57%	+38.24%	5.06B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+0.76%	+1.92%	-30.02%	-22.08%	3.95B
NOVOCURE LIMITED	+0.85%	+3.22%	+27.35%	-3.92%	1.94B
IMPLANTICA AG	+0.87%	-4.92%	-18.42%	+184.31%	1.67B
NAKANISHI INC.	-1.95%	-0.99%	+46.86%	-14.47%	1.57B
Average	+0.23%	+0.57%	+5.90%	+26.07%	4.5B
Weighted average by Cap.	+0.44%	+0.67%	+11.65%	+26.19%

	2024	2025
Net sales	116M 3.65M 3.19M 3M 2.74M 5.14M 349M 5.14M 36.02M 13.9M 178M 13.72M 13.42M 575M	179M 5.65M 4.94M 4.64M 4.24M 7.95M 540M 7.95M 55.71M 21.5M 276M 21.23M 20.76M 890M
Net income	-17.73M -560K -489K -460K -419K -787K -53.5M -787K -5.52M -2.13M -27.32M -2.1M -2.06M -88.07M	5.25M 166K 145K 136K 124K 233K 15.83M 233K 1.63M 630K 8.09M 622K 608K 26.07M
Net Debt	43.76M 1.38M 1.21M 1.13M 1.04M 1.94M 132M 1.94M 13.61M 5.25M 67.43M 5.19M 5.07M 217M	35.4M 1.12M 977K 918K 838K 1.57M 107M 1.57M 11.02M 4.25M 54.56M 4.2M 4.1M 176M